We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AVEO Seeks FDA Approval for Drug Designed to Treat Advanced Kidney Cancer
AVEO Seeks FDA Approval for Drug Designed to Treat Advanced Kidney Cancer
October 1, 2012
AVEO Oncology of Cambridge and Japanese drug maker Astellas Pharma Inc. said Friday that AVEO has submitted a new drug application to the US Food and Drug Administration for a potential treatment for advanced kidney cancer. Boston Globe
